Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Cataract
Interventions
DRUG

Ketorolac, Nepafenac

Trial Locations (1)

15213

Dr. Francis, Pittsburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Innovative Medical

INDUSTRY

NCT00348582 - Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery | Biotech Hunter | Biotech Hunter